1.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: UARK 2003-26, NCT00090493
|
|
2.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2008-0416, NCT00960752
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: UPCC 02710, UMGCC 0955, NCT01245673
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-0113, NCT01266603
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EAU RF 2010-01, NTR2846, 2010-024355-85, NCT01435356
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-16545, NCT01437605
|
|
7.
|
Phase: Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: Pro00000806, IND # BB-13545, NIH OBA # 0708-874, NCT00672542
|
|
8.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LGS 2009-005, 10-051, 10-216, NCT01380145
|